Heart Initiative Inc

“Gad cotter and beth cotter-davidson are directors and married to each other.”

“No review was or will be conducted.”

“No other documents available to the public.”

“Created in 2009. Originally, the mission of the corporation was to collaborate with cardiovascular leaders in africa to improve the early diagnosis and treatment of cardiovascular diseases and heart failure in sub-saharan africa, particularly increasing usage of proven therapies for heart failure and improve adherence. Through the course of its work, the corporation's activities and research have evolved. The corporation has partnered with momentum research, inc., lariboisire hospital in paris, and roche diagnostics to examine other aspects of early diagnosis and treatment of cardiovascular disease, specifically heart failure, beyond africa. Mission and accomplishments: during 2024 the heart initiative continued its scientific mission to improve heart failure therapy globally through two main avenues: 1. Publications and sharing of data from studies completed the heart from studies completed in 2022 and previous years and share them with the scientific community. Such examples are highlighted in the links below among the contributing members of our research organization. Https://pubmed.ncbi.nlm.nih.gov/36356631/ 2. Performing studies to promote better heart health globally, the heart initiative has continued to sponsor its largest study to date the strong-hf study which is aimed at better implementing cheap, generic therapies in patients after and admission to a hospital for heart failure. In 2022, the heart initiative secured additional sponsorship from roche diagnostics to enable expanding the study to up to 1,100 patients and continues to recruit patients to the study globally in europe, south america and subsaharan africa. In 2022, the study was completed and analyzed, presented and published. 3. The heart initiative as with its partners at isnerm have initiated a new study to explore the effects of steroids in ahf. The study title is "effect of short-term prednisone therapy on c-reactive protein change in emergency department patients with acute heart failure and elevated inflammatory markers" acute heart failure (ahf) is a common discharge diagnosis in the emergency department (ed), associated with 1-month mortality of 6%, and a 30% risk rate of 1-month rehospitalization. Current guidelines recommend the use of nitrates and low dose diuretic to treat congestion, but to date, no drug has ever shown any improved clinical outcome when given at the acute phase. Several studies suggest that there is a high inflammatory component in ahf, with elevated markers such as il6 and c-reactive protein (crp). As it is the case in other acute respiratory disease, a short course of steroid therapy may limit the inflammatory response and in turn, improve ahf prognosis. The objective of the study is to assess the effect of a 7-day course of steroid introduced in the ed on inflammatory response. The study is a parallel-group, randomized, open-label, controlled trial in 5 eds in france. Patients with ahf and high crp levels will be randomized to 7 days of prednisone therapy or control and followed for 30days. Endpoints include change in crp levels and risk of worsening hf, hf readmission or death to day 30. 4. The heart initiative and its partners in mount sinai hospital in nyc have initiated a study to assess ways to improve adherence in patients with htn and hyperlipidemia. The study entiltled: "cp&r - cardiovascular precision medicine & remote intervention". Control of hypertension and hypercholesterolemia is key to reducing risk of adverse cardiovascular outcomes in patients with cardiovascular morbidity. Non-adherence to medical recommendations is the most important reason for adverse outcomes, as blood pressure remains erratic if medication-taking is also erratic. Non-adherence can be identified by multiple subjective and objective methods, but subjective methods (patients' own reports) are not reliable, and objective methods may be misleading (if they are dependent on factors other than adherence), or cumbersome. For example, electron”

“Professional fees: program service expenses 873,813. Management and general expenses 0. Fundraising expenses 0. Total expenses 873,813.”